Quick answer: The evidence on PRP for knee osteoarthritis is mixed. A 2021 JAMA randomized trial found no significant difference from saline placebo in pain or cartilage volume at 12 months. Some meta-analyses report better pain scores than hyaluronic acid or controls, but trial quality and methods vary widely. A physician can help you weigh it against other options.
Why this question deserves a straight answer
Platelet-rich plasma (PRP) is one of the most searched regenerative treatments. It also has one of the most confusing evidence bases. You can find studies that look encouraging and a high-quality trial that found no difference from placebo. Both are real, and patients deserve to hear both. This guide walks through the strongest published evidence on PRP for knee osteoarthritis (OA), using peer-reviewed sources only.
What PRP is
PRP is made from your own blood. A sample is drawn and spun in a centrifuge to concentrate platelets in a portion of the plasma, which is then injected. Because preparation systems, platelet concentrations, and injection schedules differ, "PRP" isn't one standardized product. That variability is one reason studies disagree.
How FDA regulates PRP
A 2015 review in the Journal of Knee Surgery, by authors from the University of Connecticut, explains that blood products such as PRP fall under FDA's Center for Biologics Evaluation and Research. Under 21 CFR 1271, PRP is exempt from FDA's traditional drug pathway. PRP preparation systems reach the market as devices through 510(k) clearance. The review notes that nearly all of these systems are cleared for producing platelet-rich preparations to mix with bone graft materials in orthopedic settings. Office injection for other uses is considered off-label.
In plain terms, FDA has cleared devices that prepare PRP. It has not approved PRP injection as a treatment for knee arthritis.
The strongest single trial: RESTORE (JAMA, 2021)
The RESTORE trial, led by researchers at the University of Melbourne, is among the most rigorous PRP knee studies.
- Design: randomized, placebo-controlled; 288 adults with symptomatic mild to moderate radiographic knee OA (mean age 61.9); three injections of PRP or saline placebo.
- Pain at 12 months: mean change of −2.1 points with PRP versus −1.8 with placebo. The difference (−0.4 points; 95% CI −0.9 to 0.2) was not statistically significant.
- Cartilage: medial tibial cartilage volume changed −1.4% with PRP versus −1.2% with placebo, also not significant.
- Secondary outcomes: 29 of 31 prespecified secondary outcomes showed no significant difference.
- Authors' conclusion: the findings do not support use of PRP for managing knee OA.
Notice that both groups improved on pain. Placebo response in injection trials can be large, which is exactly why placebo-controlled studies matter.
What meta-analyses report
PRP vs hyaluronic acid
A 2023 systematic review and meta-analysis in Arthroscopy included 27 Level I studies. Patients who received PRP had significantly better post-injection WOMAC, pain (VAS), and IKDC scores than patients who received hyaluronic acid (HA). This compares PRP with another injection, not with placebo.
PRP vs controls across joints
A 2023 meta-analysis in Frontiers in Medicine pooled 24 randomized trials (1,344 patients) across several joints. For knee OA, PRP improved VAS pain scores versus controls (mean difference −1.03). The authors also reported high statistical heterogeneity (I² = 87% for knee pain), which means results varied a lot between studies.
How to reconcile the two pictures
- Many trials compare PRP with HA or other active treatments, not saline.
- PRP preparations, doses, and schedules vary between studies.
- Pooled results are only as reliable as the trials they combine. High heterogeneity is a caution flag.
- RESTORE was large, placebo-controlled, and preregistered, so it carries real weight.
A fair summary: some patients and some studies show improvement, but high-quality placebo-controlled evidence for knee OA is not consistent. Nobody can promise that PRP will help a particular knee.
Why "it worked for my friend" isn't evidence
Personal stories matter, but they can't separate PRP's effect from placebo response, natural ups and downs in arthritis pain, or other treatments happening at the same time. In RESTORE, the saline group's pain also improved by an average of 1.8 points. That's why placebo-controlled trials, not testimonials, are the standard for judging whether a treatment works.
Who might discuss PRP with a physician
We don't diagnose through a blog. A physician visit for knee pain usually covers:
- Diagnosis first. Is it osteoarthritis, a meniscus problem, tendon pain, or something else? Imaging and exam matter.
- Standard options. Exercise therapy, weight management, and other approaches your clinician may recommend.
- Expectations. What published trials show, including the null placebo-controlled findings.
- Practicalities. How PRP is prepared, what device is used, and the off-label status.
If you're curious about PRP for other uses, our PRP hair restoration article covers a different evidence base.
Frequently asked questions
Does PRP work for knee arthritis?
The evidence is mixed. The 2021 RESTORE trial in JAMA found no significant difference between PRP and saline placebo in knee pain or cartilage volume at 12 months. Some meta-analyses report better pain scores with PRP than with hyaluronic acid or controls, but study quality and methods vary widely.
Is PRP better than hyaluronic acid injections?
A 2023 Arthroscopy meta-analysis of 27 Level I studies reported significantly better WOMAC, pain, and IKDC scores after PRP than after hyaluronic acid. That compares two injections head to head. It doesn't settle whether PRP beats placebo, which RESTORE did not find.
Is PRP FDA-approved for knees?
No. According to a review of FDA's stance, PRP preparation systems are cleared as devices through 510(k), mostly for mixing with bone graft materials. Injecting PRP into a knee in an office is considered off-label use, which clinicians may do within their professional responsibilities.
Does PRP regrow cartilage?
In RESTORE, cartilage volume changed by −1.4% with PRP and −1.2% with placebo over 12 months, with no significant difference. Published evidence does not show that PRP rebuilds knee cartilage.
Is PRP safe?
PRP is made from your own blood, but it is still an injection, and every injection carries some risk. The studies above focused mainly on whether PRP helps, so a physician should go over the specific risks with you. Those depend on the joint, the preparation, and your health history.
Talk with a Regen Therapy MD physician
If you'd like to talk through whether any of these options fit your health history, start with a physician consult, not a product.
- Book a consult: https://book.mypatientnow.com/practice/TqZLiT
- Call: (424) 349-6008
- Cost: $295 consult (physician visit)
- Clinics: Beverly Hills and Santa Monica. Telehealth and peptide shipping are available only where we are licensed.
Sources
- Bennell KL, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021. PMID 34812863. https://pubmed.ncbi.nlm.nih.gov/34812863/
- Belk JW, et al. Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid. Arthroscopy. 2023. PMID 36913992. https://pubmed.ncbi.nlm.nih.gov/36913992/
- Xiong Y, et al. Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Front Med. 2023. PMID 37441691. https://pubmed.ncbi.nlm.nih.gov/37441691/
- Beitzel K, et al. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg. 2015. PMID 25268794. https://pubmed.ncbi.nlm.nih.gov/25268794/
Educational disclaimer
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. It doesn't establish a doctor-patient relationship or confirm that you are a candidate for any therapy. Individual results vary, and no outcome is promised. Study figures are group results from the cited publications, not predictions for any individual. Compounded drugs are not FDA-approved, and FDA-approved brand products and compounded preparations are not interchangeable. Retatrutide is investigational. This article doesn't provide dosing or treatment protocols. Talk with a licensed clinician about your own situation. If you have a medical emergency, call 911.
.svg)
